TRV
Third Rock Ventures Portfolio holdings
AUM
$1.07B
This Quarter Return
-1.18%
1 Year Return
+201.55%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.07B
AUM Growth
+$1.07B
(+11%)
Cap. Flow
+$428M
Cap. Flow
% of AUM
39.97%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$622M |
Top Sells
| 1 |
SAGE
Sage Therapeutics
SAGE
|
$98.6M |
| 2 |
Larimar Therapeutics
LRMR
|
$95.6M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
1
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $622M | 58.1% | +14,760,900 | New | +$622M |
|
|
SAGE
2
DELISTED
Sage Therapeutics
SAGE
| $273M | 25.46% | 6,442,916 -2,330,157 | -27% | -$98.6M |
|
|
BPMC
3
DELISTED
Blueprint Medicines
BPMC
| $158M | 14.73% | 7,393,059 | – | – |
|
4
Carisma Therapeutics
CARM
$8.98M
| $11.7M | 1.09% | 4,841,591 | – | – |
|
|
5
Larimar Therapeutics
LRMR
$310M
| $6.72M | 0.63% | 210,371 -2,991,674 | -93% | -$95.6M |
|